Showing results (151-160 of 161) with videos related to
Sort By:
Pageof 17
The Journal of Thoracic and Cardiovascular Surgery|February 28, 2026
Pathologic complete response after neoadjuvant immunochemotherapy: persistent recurrence risk highlights the need for stratified managementChang Yuan, Chunji Chen, Zhichao Liu, et al.Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|January 25, 2026
Association of immune-related adverse events with survival outcomes in esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapy: a national multicenter retrospective cohort study in ChinaChunji Chen, Chang Yuan, Zhichao Liu, et al.Journal of the National Cancer Center|July 22, 2024
Minimally invasive versus open esophagectomy for resectable thoracic esophageal cancer (NST 1502): a multicenter prospective cohort studyYousheng Mao, Shugeng Gao, Yin Li, et al.Molecular Cancer|May 15, 2025
Perioperative nivolumab and chemotherapy in locally advanced squamous cell carcinoma of the oesophagus: a randomized multicentre phase 2 study with circulating tumor DNA dynamics monitoringHeng Jiao, Siyun Lin, Jianmin Gu, et al.Cancer Research|July 11, 2023
Intratumoral Microbiota Composition Regulates Chemoimmunotherapy Response in Esophageal Squamous Cell CarcinomaHong Wu, Xuefeng Leng, Qianshi Liu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2025
Neoadjuvant Osimertinib for Resectable <i>EGFR</i>-Mutated Non-Small Cell Lung CancerJianxing He, Masahiro Tsuboi, Walter Weder, et al.Annals of Translational Medicine|November 18, 2021
Pathological complete response after neoadjuvant treatment determines survival in esophageal squamous cell carcinoma patients (NEOCRTEC5010)Jianfei Shen, Min Kong, Hong Yang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 9, 2018
Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical TrialHong Yang, Hui Liu, Yuping Chen, et al.Nature Medicine|July 2, 2024
Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trialJianjun Qin, Liyan Xue, Anlin Hao, et al.Translational Lung Cancer Research|January 10, 2022
Expert consensus on resection of chest wall tumors and chest wall reconstructionLei Wang, Xiaolong Yan, Jinbo Zhao, et al.Pageof 17